Haplotypes of the D-amino acid oxidase gene are significantly associated with schizophrenia and its neurocognitive deficits

PLoS ONE

Volumn 11, Issue 3, 2016, Pages

  Liu, Yu Li ^a,b   Wang, Sheng Chang ^a   Hwu, Hai Gwo ^b,c   Fann, Cathy Shen Jang ^d   Yang, Ueng Cheng ^e   Yang, Wei Chih ^d   Hsu, Pei Chun ^f   Chang, Chien Ching ^d   Wen, Chun Chiang ^b   Tsai Wu, Jyy Jih ^b   Hwang, Tzung Jeng ^b,c   Hsieh, Ming H ^b   Liu, Chen Chung ^b,c   Chien, Yi Ling ^b   Fang, Chiu Ping ^a   Faraone, Stephen V ^g   Tsuang, Ming T ^h,i   Chen, Wei J ^f   Liu, Chih Min ^b,c  

^a NATIONAL HEALTH RESEARCH INSTITUTES   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d INSTITUTE OF BIOMEDICAL SCIENCES   (Taiwan)

^e NATIONAL YANG MING UNIVERSITY   (Taiwan)

^f NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^g SUNY UPSTATE MEDICAL UNIVERSITY   (United States)

^h HARVARD MEDICAL SCHOOL   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXTRO AMINO ACID OXIDASE; MESSENGER RNA;

ADULT; AGED; ALLELE; ARTICLE; ATTENTION; CONTROLLED STUDY; DAO GENE; DISORDERS OF HIGHER CEREBRAL FUNCTION; EXECUTIVE FUNCTION; EXON; FEMALE; GENE EXPRESSION; GENE LOCUS; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; INTRON; LYMPHOCYTE; MAJOR CLINICAL STUDY; MALE; MISMATCH NEGATIVITY; NEUROPSYCHOLOGICAL TEST; PROMOTER REGION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCHIZOPHRENIA; SEQUENCE ALIGNMENT; SINGLE NUCLEOTIDE POLYMORPHISM; ADOLESCENT; GENETIC PREDISPOSITION; GENETICS; YOUNG ADULT;

ADOLESCENT; ADULT; D-AMINO-ACID OXIDASE; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; SCHIZOPHRENIA; YOUNG ADULT;

EID: 84978032854     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0150435     Document Type: Article

References (59)

1. Schell MJ. The N-methyl D-aspartate receptor glycine site and D-serine metabolism: an evolutionary perspective. Philos Trans R Soc Lond B Biol Sci. 2004; 359(1446):943-64. Epub 2004/08/13. doi: 10.1098/rstb.2003.1399 BJYG8C0DVBQP03R0 [pii]. PMID: 15306409; PubMed Central PMCID: PMC1693380.
2. Wood LS, Pickering EH, Dechairo BM. Significant support for DAO as a schizophrenia susceptibility locus: examination of five genes putatively associated with schizophrenia. Biol Psychiatry. 2007; 61 (10):1195-9. PMID: 17055463.
3. Verrall L, Burnet PW, Betts JF, Harrison PJ. The neurobiology of D-amino acid oxidase and its involvement in schizophrenia. Mol Psychiatry. 2010; 15(2):122-37. Epub 2009/09/30. doi: 10.1038/mp.2009. 99 PMID: 19786963; PubMed Central PMCID: PMC2811712.
4. Chumakov I, Blumenfeld M, Guerassimenko O, Cavarec L, Palicio M, Abderrahim H, et al. Genetic and physiological data implicating the new human gene G72 and the gene for D-amino acid oxidase in schizophrenia. Proc Natl Acad Sci U S A. 2002; 99(21):13675-80. PMID: 12364586.
5. Schumacher J, Jamra RA, Freudenberg J, Becker T, Ohlraun S, Otte AC, et al. Examination of G72 and D-amino-acid oxidase as genetic risk factors for schizophrenia and bipolar affective disorder. Mol Psychiatry. 2004; 9(2):203-7. PMID: 14966479.
6. Corvin A, McGhee KA, Murphy K, Donohoe G, Nangle JM, Schwaiger S, et al. Evidence for association and epistasis at the DAOA/G30 and D-amino acid oxidase loci in an Irish schizophrenia sample. Am J Med Genet B Neuropsychiatr Genet. 2007; 144(7):949-53. PMID: 17492767.
7. Liu X, He G, Wang X, Chen Q, Qian X, Lin W, et al. Association of DAAO with schizophrenia in the Chinese population. Neurosci Lett. 2004; 369(3):228-33. PMID: 15464270.
8. Liu YL, Fann CS, Liu CM, Chang CC, Wu JY, Hung SI, et al. No association of G72 and D-amino acid oxidase genes with schizophrenia. Schizophr Res. 2006; 87(1-3):15-20. PMID: 16842973.
9. Gottesman II, Gould TD. The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry. 2003; 160(4):636-45. Epub 2003/04/02. PMID: 12668349.
10. Beck LH, Bransome ED Jr., Mirsky AF, Rosvold HE, Sarason I. A continuous performance test of brain damage. J Consult Psychol. 1956; 20(5):343-50. Epub 1956/10/01. PMID: 13367264.
11. Faraone SV, Seidman LJ, Kremen WS, Toomey R, Pepple JR, Tsuang MT. Neuropsychological functioning among the nonpsychotic relatives of schizophrenic patients: a 4-year follow-up study. J Abnorm Psychol. 1999; 108(1):176-81. PMID: 10067004.
12. Faraone SV, Kremen WS, Lyons MJ, Pepple JR, Seidman LJ, Tsuang MT. Diagnostic accuracy and linkage analysis: how useful are schizophrenia spectrum phenotypes? Am J Psychiatry. 1995; 152 (9):1286-90. PMID: 7653682.
13. Cornblatt BA, Keilp JG. Impaired attention, genetics, and the pathophysiology of schizophrenia. Schizophr Bull. 1994; 20(1):31-46. Epub 1994/01/01. PMID: 8197420.
14. Chen WJ, Faraone SV. Sustained attention deficits as markers of genetic susceptibility to schizophrenia. Am J Med Genet. 2000; 97(1):52-7. PMID: 10813804.
15. Faraone SV, Seidman LJ, Kremen WS, Toomey R, Pepple JR, Tsuang MT. Neuropsychologic functioning among the nonpsychotic relatives of schizophrenic patients: the effect of genetic loading. Biol Psychiatry. 2000; 48(2):120-6. PMID: 10903408.
16. Chen WJ. Diagnostic Interview for Genetic Studies (DIGS) Mandarin version 2.01998.
17. Chen WJ, Chang CH, Liu SK, Hwang TJ, Hwu HG. Sustained attention deficits in nonpsychotic relatives of schizophrenic patients: a recurrence risk ratio analysis. Biol Psychiatry. 2004; 55(10):995-1000. PMID: 15121483.
18. Goldberg TE, Weinberger DR, Berman KF, Pliskin NH, Podd MH. Further evidence for dementia of the prefrontal type in schizophrenia? A controlled study of teaching the Wisconsin Card Sorting Test. Arch Gen Psychiatry. 1987; 44(11):1008-14. Epub 1987/11/01. PMID: 3675128.
19. Koren D, Seidman LJ, Harrison RH, Lyons MJ, Kremen WS, Caplan B, et al. Factor structure of the Wisconsin Card Sorting Test: dimensions of deficit in schizophrenia. Neuropsychology. 1998; 12(2):289-302. Epub 1998/04/29. PMID: 9556775.
20. Wolf LE, Cornblatt BA, Roberts SA, Shapiro BM, Erlenmeyer-Kimling L. Wisconsin Card Sorting deficits in the offspring of schizophrenics in the New York High-Risk Project. Schizophr Res. 2002; 57(2-3):173. Epub 2002/09/12. S0920996401003012 [pii]. PMID: 12223248.
21. Robinson AL, Heaton RK, Lehman RA, Stilson DW. The utility of the Wisconsin Card Sorting Test in detecting and localizing frontal lobe lesions. J Consult Clin Psychol. 1980; 48(5):605-14. Epub 1980/10/01. PMID: 7410659.
22. Hwu HG, Chen CH, Hwang TJ, Liu CM, Cheng JJ, Lin SK, et al. Symptom patterns and subgrouping of schizophrenic patients: significance of negative symptoms assessed on admission. Schizophr Res. 2002; 56(1-2):105-19. PMID: 12084425.
23. Hwu HG, Faraone SV, Liu CM, Chen WJ, Liu SK, Shieh MH, et al. Taiwan schizophrenia linkage study: the field study. Am J Med Genet B Neuropsychiatr Genet. 2005; 134(1):30-6. PMID: 15685625.
24. Faraone SV, Hwu HG, Liu CM, Chen WJ, Tsuang MM, Liu SK, et al. Genome scan of Han Chinese schizophrenia families from Taiwan: confirmation of linkage to 10q22.3. Am J Psychiatry. 2006; 163 (10):1760-6. PMID: 17012687.
25. Hwu HG. Psychiatric diagnostic assessment. 2nd ed. ed: Publication Committee, College of Medicine, National Taiwan University Taipei.; 1999.
26. Chen CH, Lee YR, Chung MY, Wei FC, Koong FJ, Shaw CK, et al. Systematic mutation analysis of the catechol O-methyltransferase gene as a candidate gene for schizophrenia. Am J Psychiatry. 1999; 156 (8):1273-5. PMID: 10450274.
27. Chang SS, Liu CM, Lin SH, Hwu HG, Hwang TJ, Liu SK, et al. Impaired flush response to niacin skin patch among schizophrenia patients and their nonpsychotic relatives: the effect of genetic loading. Schizophr Bull. 2009; 35(1):213-21. Epub 2008/01/22. doi: 10.1093/schbul/sbm153 PMID: 18203758; PubMed Central PMCID: PMC2643969.
28. Pan WH, Fann CS, Wu JY, Hung YT, Ho MS, Tai TH, et al. Han Chinese cell and genome bank in Taiwan: purpose, design and ethical considerations. Hum Hered. 2006; 61(1):27-30. PMID: 16534213.
29. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition (DSM-IV). Washington, DC.: American Psychiatric Publishing, Inc.; 1994.
30. Lin YT, Liu CM, Chiu MJ, Liu CC, Chien YL, Hwang TJ, et al. Differentiation of schizophrenia patients from healthy subjects by mismatch negativity and neuropsychological tests. PloS one. 2012; 7(4): e34454. doi: 10.1371/journal.pone.0034454 PMID: 22496807; PubMed Central PMCID: PMC3320618.
31. Fu CL, Yang UC. ISVdb: Integrated splicing variants database [Master thesis]. Institute of Biochemistry and Molecular Biology: National Yang-Ming University; 2004.
32. Schwartz S, Zhang Z, Frazer KA, Smit A, Riemer C, Bouck J, et al. PipMaker - a web server for aligning two genomic DNA sequences. Genome Res. 2000; 10(4):577-86. Epub 2000/04/26. PMID: 10779500; PubMed Central PMCID: PMC310868.
33. Schwartz S, Elnitski L, Li M, Weirauch M, Riemer C, Smit A, et al. MultiPipMaker and supporting tools: Alignments and analysis of multiple genomic DNA sequences. Nucleic Acids Res. 2003; 31(13):3518-24. Epub 2003/06/26. PMID: 12824357; PubMed Central PMCID: PMC168985.
34. Rozen S, Skaletsky H. Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol. 2000; 132:365-86. PMID: 10547847.
35. Rodi CP, Darnhofer-Patel B, Stanssens P, Zabeau M, van den Boom D. A strategy for the rapid discovery of disease markers using the MassARRAY system. Biotechniques. 2002;Suppl: :62-6, 8-9. Epub 2002/06/27. PMID: 12083400.
36. Tost J, Gut IG. Genotyping single nucleotide polymorphisms by MALDI mass spectrometry in clinical applications. Clin Biochem. 2005; 38(4):335-50. PMID: 15766735.
37. Nuechterlein KH. Vigilance in schizophrenia and related disorders. Steinhauer SR, Gruzelier JH, Zubin J, editors. Amsterdam: Elsevier; 1991. 397-433 p.
38. Tien AY, Spevack TV, Jones DW, Pearlson GD, Schlaepfer TE, Strauss ME. Computerized Wisconsin Card Sorting Test: comparison with manual administration. Kaohsiung J Med Sci. 1996; 12(8):479-85. Epub 1996/08/01. PMID: 8774117.
39. Heaton RK, Chelune GI, Talley JL, Kay GG, Curtiss G. Wisconsin Card Sorting Test Manual: Revised and Expanded. Odessa, FL: Psychological Assessment Resources; 1993.
40. Wynn JK, Sugar C, Horan WP, Kern R, Green MF. Mismatch negativity, social cognition, and functioning in schizophrenia patients. Biol Psychiatry. 2010; 67(10):940-7. doi: 10.1016/j.biopsych.2009.11.024 PMID: 20074704; PubMed Central PMCID: PMC2862843.
41. Light GA, Braff DL. Mismatch negativity deficits are associated with poor functioning in schizophrenia patients. Arch Gen Psychiatry. 2005; 62(2):127-36. doi: 10.1001/archpsyc.62.2.127 PMID: 15699289.
42. Inc. SI. SAS/Genetics® User's guide. Cary, North Carolina: SAS Institute Inc.; 2002.
43. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B, et al. The structure of haplotype blocks in the human genome. Science. 2002; 296(5576):2225-9. Epub 2002/05/25. doi: 10.1126/science.1069424 1069424 [pii]. PMID: 12029063.
44. Benjamini Y, Hochberg Y. Controlling the false discovery rate: a practical and powerful approach to multiple testing. J R Statist Soc B. 1995; 57(1):289-300.
45. Schizophrenia Working Group of the Psychiatric Genomics C. Biological insights from 108 schizophrenia-associated genetic loci. Nature. 2014; 511(7510):421-7. doi: 10.1038/nature13595 PMID: 25056061; PubMed Central PMCID: PMC4112379.
46. Yang HC, Lin CH, Hsu CL, Hung SI, Wu JY, Pan WH, et al. A comparison of major histocompatibility complex SNPs in Han Chinese residing in Taiwan and Caucasians. J Biomed Sci. 2006; 13(4):489-98. doi: 10.1007/s11373-006-9077-7 PMID: 16544196.
47. Ikeda M, Aleksic B, Kinoshita Y, Okochi T, Kawashima K, Kushima I, et al. Genome-wide association study of schizophrenia in a Japanese population. Biol Psychiatry. 2011; 69(5):472-8. doi: 10.1016/j.biopsych.2010.07.010 PMID: 20832056.
48. Wong EH, So HC, Li M, Wang Q, Butler AW, Paul B, et al. Common variants on Xq28 conferring risk of schizophrenia in Han Chinese. Schizophr Bull. 2014; 40(4):777-86. doi: 10.1093/schbul/sbt104 PMID: 24043878; PubMed Central PMCID: PMC4059435.
49. Umbricht D, Koller R, Vollenweider FX, Schmid L. Mismatch negativity predicts psychotic experiences induced by NMDA receptor antagonist in healthy volunteers. Biol Psychiatry. 2002; 51(5):400-6. PMID: 11904134.
50. Umbricht D, Krljes S. Mismatch negativity in schizophrenia: a meta-analysis. Schizophr Res. 2005; 76 (1):1-23. doi: 10.1016/j.schres.2004.12.002 PMID: 15927795.
51. Coyle JT. NMDA receptor and schizophrenia: a brief history. Schizophr Bull. 2012; 38(5):920-6. doi: 10.1093/schbul/sbs076 PMID: 22987850; PubMed Central PMCID: PMC3446237.
52. Burnet PW, Eastwood SL, Bristow GC, Godlewska BR, Sikka P, Walker M, et al. D-amino acid oxidase activity and expression are increased in schizophrenia. Mol Psychiatry. 2008; 13(7):658-60. Epub 2008/06/19. doi: 10.1038/mp.2008.47 PMID: 18560437; PubMed Central PMCID: PMC2629619.
53. Madeira C, Freitas ME, Vargas-Lopes C, Wolosker H, Panizzutti R. Increased brain D-amino acid oxidase (DAAO) activity in schizophrenia. Schizophr Res. 2008; 101(1-3):76-83. Epub 2008/04/02. doi: 10.1016/j.schres.2008.02.002 PMID: 18378121.
54. Bendikov I, Nadri C, Amar S, Panizzutti R, De Miranda J, Wolosker H, et al. A CSF and postmortem brain study of D-serine metabolic parameters in schizophrenia. Schizophr Res. 2007; 90(1-3):41-51. Epub 2006/12/13. doi: 10.1016/j.schres.2006.10.010 PMID: 17156977.
55. Verrall L, Walker M, Rawlings N, Benzel I, Kew JN, Harrison PJ, et al. d-Amino acid oxidase and serine racemase in human brain: normal distribution and altered expression in schizophrenia. Eur J Neurosci. 2007; 26(6):1657-69. Epub 2007/09/21. doi: 10.1111/j.1460-9568.2007.05769.x PMID: 17880399; PubMed Central PMCID: PMC2121142.
56. Kapoor R, Lim KS, Cheng A, Garrick T, Kapoor V. Preliminary evidence for a link between schizophrenia and NMDA-glycine site receptor ligand metabolic enzymes, d-amino acid oxidase (DAAO) and kynurenine aminotransferase-1 (KAT-1). Brain Res. 2006; 1106(1):205-10. Epub 2006/07/11. doi: 10.1016/j.brainres.2006.05.082 PMID: 16828464.
57. Roussos P, Giakoumaki SG, Adamaki E, Anastasios G, Nikos RK, Bitsios P. The association of schizophrenia risk D-amino acid oxidase polymorphisms with sensorimotor gating, working memory and personality in healthy males. Neuropsychopharmacology. 2011; 36(8):1677-88. Epub 2011/04/08. doi: 10.1038/npp.2011.49 PMID: 21471957; PubMed Central PMCID: PMC3138651.
58. Papagni SA, Mechelli A, Prata DP, Kambeitz J, Fu CH, Picchioni M, et al. Differential effects of DAAO on regional activation and functional connectivity in schizophrenia, bipolar disorder and controls. Neuroimage. 2011; 56(4):2283-91. Epub 2011/03/23. doi: 10.1016/j.neuroimage.2011.03.037 PMID: 21421061.
59. Goldberg TE, Straub RE, Callicott JH, Hariri A, Mattay VS, Bigelow L, et al. The G72/G30 gene complex and cognitive abnormalities in schizophrenia. Neuropsychopharmacology. 2006; 31(9):2022-32. Epub 2006/03/24. doi: 10.1038/sj.npp.1301049 PMID: 16554747.